LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Lakefront Biotherapeutics NV
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$29.79−0.11 (-0.37%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
32M
Shares held, 13F filers
Institutional holders
77
9 new, 21 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Oleg Nodelman | 8,714,522 | 13.22% | 13D (active) amendment | Jul 24, 2025 |
| EcoR1 Capital, LLC | 7,803,202 | 11.84% | 13D (active) amendment | May 15, 2025 |
| Kevin Tang | 5,559,674 | 8.40% | 13G (passive) | Oct 27, 2025 |
| Eli Samaha | 3,606,203 | 5.50% | 13G (passive) | Jun 15, 2026 |
| Gilead Sciences, Inc. | 20,981,010 | 29.90% | 13D (active) amendment | Jan 7, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LKFT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 16,707,477 | – | $500.16M | – | 30.34% |
| Tang Capital Management LLC | 3,785,991 | – | $113.50M | – | 5.16% |
| Madison Avenue Partners, LP | 3,447,807 | – | $103.37M | +982,628 | 4.45% |
| Prosight Management, LP | 2,043,344 | – | $61.26M | +493,344 | 10.56% |
| EcoR1 Capital, LLC | 1,667,119 | – | $49.98M | – | 2.43% |
| Ameriprise Financial Inc | 1,272,249 | – | $38.14M | −152,425 | 0.01% |
| DME Capital Management, LP | 482,746 | – | $14.47M | – | 0.37% |
| Renaissance Technologies LLC | 407,800 | – | $12.23M | +92,400 | 0.02% |
| BlackRock, Inc. | 338,152 | – | $10.14M | +26,046 | 0.00% |
| Point72 Asset Management, L.P. | 269,814 | – | $8.09M | −62,311 | 0.01% |
| D. E. Shaw & Co., Inc. | 197,844 | – | $5.93M | −17,874 | 0.00% |
| Millennium Management LLC | 181,090 | – | $5.43M | +73,178 | 0.00% |
| UBS Group AG | 168,148 | – | $5.04M | −7,141 | 0.00% |
| Susquehanna International Group, Llp | 151,886 | – | $4.55M | +138,499 | 0.00% |
| DAFNA Capital Management LLC | 130,175 | – | $3.90M | – | 0.74% |
| Citadel Advisors LLC | 88,343 | – | $2.65M | −36,085 | 0.00% |
| Two Sigma Investments, LP | 81,749 | – | $2.45M | +55,889 | 0.00% |
| Norges Bank | 76,879 | – | $2.30M | New | 0.00% |
| Alps Advisors Inc | 65,523 | – | $1.96M | +11,862 | 0.01% |
| Goldman Sachs Group Inc | 56,581 | – | $1.70M | +11,210 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 32M | 9 / 26 | 28 / 21 | 2M | 1M |
| Q1 2026 | 90 | 31M | 16 / 33 | 28 / 15 | 1M | 1M |
| Q4 2025 | 91 | 31M | 16 / 28 | 33 / 16 | 1M | 1M |
| Q3 2025 | 92 | 31M | 18 / 31 | 29 / 11 | 3M | 3M |
| Q2 2025 | 85 | 32M | 21 / 25 | 24 / 18 | 5M | 4M |
| Q1 2025 | 83 | 31M | 17 / 22 | 30 / 15 | 3M | 3M |
| Q4 2024 | 81 | 31M | 12 / 24 | 24 / 10 | 19M | 2M |
| Q3 2024 | 79 | 14M | 11 / 25 | 24 / 16 | 2M | 8M |
| Q2 2024 | 85 | 20M | 12 / 38 | 18 / 9 | 1M | 2M |
| Q1 2024 | 82 | 21M | 9 / 27 | 28 / 14 | 2M | 1M |
| Q4 2023 | 88 | 20M | 20 / 36 | 17 / 5 | 2M | 1M |
| Q3 2023 | 73 | 20M | 6 / 32 | 20 / 8 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of LKFT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Columbia Overseas Value Fund | 746,801 | – | $21.17M | 0.31% | May 31, 2026 |
| iShares Biotechnology ETF | 292,580 | – | $8.77M | 0.10% | Jun 30, 2026 |
| Columbia Variable Portfolio - Overseas Core Fund | 280,317 | – | $8.40M | 0.22% | Jun 30, 2026 |
| Columbia Overseas Core Fund | 90,697 | – | $2.57M | 0.26% | May 31, 2026 |
| ALPS Medical Breakthroughs ETF | 67,945 | – | $1.93M | 1.19% | May 31, 2026 |
| Avantis International Equity ETF | 30,449 | – | $863.23K | 0.01% | May 31, 2026 |
| International Value Fund | 28,283 | – | $801.82K | 0.16% | May 31, 2026 |
| ActivePassive International Equity ETF | 18,273 | – | $518.04K | 0.05% | May 31, 2026 |
| Steward Values Enhanced International Fund | 16,569 | – | $450.84K | 0.13% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 10,150 | – | $287.75K | 0.00% | May 31, 2026 |
| Avantis International Small Cap Equity ETF | 6,762 | – | $191.70K | 0.06% | May 31, 2026 |
| Avantis International Equity Fund | 2,478 | – | $70.25K | 0.01% | May 31, 2026 |
| Invesco Nasdaq Biotechnology ETF | 794 | – | $22.51K | 0.03% | May 31, 2026 |
| ProShares Ultra Nasdaq Biotechnology | 548 | – | $15.54K | 0.02% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 100 | – | $3.00K | 0.00% | Jun 30, 2026 |